LTRN (STOCKS)
Lantern Pharma Inc. Common Stock
$2.140000
+0.170000 (+8.63%)
Prev close: $1.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Panna L. Sharma
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $24.76M
- Employees
- 24
- P/E (TTM)
- -1.25
- P/B (TTM)
- 3.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $17.98M |
| Depreciation and Amortization | $17.28K |
| Research and Development | $11.51M |
| Other Operating Expenses | $6.45M |
| Operating Income/Loss | -$17.98M |
| Income/Loss From Continuing Operations After Tax | -$17.12M |
| Income/Loss From Continuing Operations Before Tax | -$17.12M |
| Net Income/Loss | -$17.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.57 |
| Diluted Earnings Per Share | -$1.57 |
| Basic Average Shares | 10,898,175 |
| Diluted Average Shares | 10,898,175 |
| Assets | $11.04M |
| Current Assets | $10.80M |
| Noncurrent Assets | $232.64K |
| Fixed Assets | $31.88K |
| Other Non-current Assets | $200.76K |
| Liabilities | $4.50M |
| Current Liabilities | $4.50M |
| Noncurrent Liabilities | $0.00 |
| Equity | $6.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.53M |
| Liabilities And Equity | $11.04M |
| Net Cash Flow From Operating Activities | -$15.68M |
| Net Cash Flow From Operating Activities, Continuing | -$15.68M |
| Net Cash Flow From Investing Activities | $11.06M |
| Net Cash Flow From Investing Activities, Continuing | $11.06M |
| Net Cash Flow From Financing Activities | $1.50M |
| Net Cash Flow From Financing Activities, Continuing | $1.50M |
| Net Cash Flow | -$3.12M |
| Net Cash Flow, Continuing | -$3.12M |
| Comprehensive Income/Loss | -$17.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.25M |
| Other Comprehensive Income/Loss | -$128.56K |